Epigenetic PTEN Silencing in Malignant Melanomas without PTEN Mutation
Xiaoping Zhou(Merck & Co., Inc., Rahway, NJ, USA (United States)), Charis Eng(Cleveland Clinic)
Cited by 273
Related Papers
Localization of the gene for Cowden disease to chromosome 10q22–23
|Nature Genetics|1996|670
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition
|Journal of Pharmacology and Experimental Therapeutics|2015|336
Differential Nuclear and Cytoplasmic Expression of PTEN in Normal Thyroid Tissue, and Benign and Malignant Epithelial Thyroid Tumors
|American Journal Of Pathology|2000|320
Frequent Loss of PTEN Expression Is Linked to Elevated Phosphorylated Akt Levels, but Not Associated with p27 and Cyclin D1 Expression, in Primary Epithelial Ovarian Carcinomas
|American Journal Of Pathology|2001|254
Germline Inactivation of PTEN and Dysregulation of the Phosphoinositol-3-Kinase/Akt Pathway Cause Human Lhermitte-Duclos Disease in Adults
|The American Journal of Human Genetics|2003|230